Literature DB >> 29523062

Enteroviruses: Classification, Diseases They Cause, and Approaches to Development of Antiviral Drugs.

O S Nikonov1, E S Chernykh, M B Garber, E Yu Nikonova.   

Abstract

The genus Enterovirus combines a portion of small (+)ssRNA-containing viruses and is divided into 10 species of true enteroviruses and three species of rhinoviruses. These viruses are causative agents of the widest spectrum of severe and deadly epidemic diseases of higher vertebrates, including humans. Their ubiquitous distribution and high pathogenicity motivate active search to counteract enterovirus infections. There are no sufficiently effective drugs targeted against enteroviral diseases, thus treatment is reduced to supportive and symptomatic measures. This makes it extremely urgent to develop drugs that directly affect enteroviruses and hinder their development and spread in infected organisms. In this review, we cover the classification of enteroviruses, mention the most common enterovirus infections and their clinical manifestations, and consider the current state of development of anti-enteroviral drugs. One of the most promising targets for such antiviral drugs is the viral Internal Ribosome Entry Site (IRES). The classification of these elements of the viral mRNA translation system is also examined.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29523062      PMCID: PMC7087576          DOI: 10.1134/S0006297917130041

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  17 in total

1.  Assessment of rotavirus and norovirus emitted from water spray park: QMRA, diseases burden and sensitivity analysis.

Authors:  Hasan Pasalari; Hesam Akbari; Angila Ataei-Pirkooh; Amir Adibzadeh; Hamed Akbari
Journal:  Heliyon       Date:  2022-10-07

2.  Characterization of G-Quadruplexes in Enterovirus A71 Genome and Their Interaction with G-Quadruplex Ligands.

Authors:  Lu Lv; Leiliang Zhang
Journal:  Microbiol Spectr       Date:  2022-04-21

3.  Autophagy is induced and supports virus replication in Enterovirus A71-infected human primary neuronal cells.

Authors:  Jhao-Yin Lin; Hsing-I Huang
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

4.  Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China.

Authors:  Xiao-Dan Meng; Yeqing Tong; Zhen-Ni Wei; Lei Wang; Jian-Yi Mai; Yang Wu; Zhi-Yu Luo; Shaoping Li; Meng Li; Siquan Wang; Sheng Wei; Wensheng Gong; Wangsheng Zhang; Xingzhou Hu; Jiao Huang; Jing Shi; Gang Yang; Shengli Meng; Zejun Wang; Xuhua Guan; Shuo Shen
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

Review 5.  Exosome therapeutics for COVID-19 and respiratory viruses.

Authors:  Kristen D Popowski; Phuong-Uyen C Dinh; Arianna George; Halle Lutz; Ke Cheng
Journal:  View (Beijing)       Date:  2021-01-31

Review 6.  Enterovirus A71 Vaccines.

Authors:  Mei-Ling Li; Shin-Ru Shih; Blanton S Tolbert; Gary Brewer
Journal:  Vaccines (Basel)       Date:  2021-02-27

Review 7.  The Antiviral Effects of Na,K-ATPase Inhibition: A Minireview.

Authors:  Luciano Amarelle; Emilia Lecuona
Journal:  Int J Mol Sci       Date:  2018-07-24       Impact factor: 5.923

8.  Genetic and phenotypic characterization of recently discovered enterovirus D type 111.

Authors:  Serge Alain Sadeuh-Mba; Marie-Line Joffret; Arthur Mazitchi; Marie-Claire Endegue-Zanga; Richard Njouom; Francis Delpeyroux; Ionela Gouandjika-Vasilache; Maël Bessaud
Journal:  PLoS Negl Trop Dis       Date:  2019-10-17

9.  Rules governing genetic exchanges among viral types from different Enterovirus A clusters.

Authors:  Min Wang; Liuyao Zhu; Jun Fan; Jingjing Yan; Ying Dun; Rui Yu; Lizhen Liu; Shuye Zhang
Journal:  J Gen Virol       Date:  2020-11       Impact factor: 3.891

10.  Defining the proteolytic landscape during enterovirus infection.

Authors:  Mohsan Saeed; Sebastian Kapell; Nicholas T Hertz; Xianfang Wu; Kierstin Bell; Alison W Ashbrook; Milica Tesic Mark; Henry A Zebroski; Maxwell L Neal; Malin Flodström-Tullberg; Margaret R MacDonald; John D Aitchison; Henrik Molina; Charles M Rice
Journal:  PLoS Pathog       Date:  2020-09-30       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.